Starz Entertainment Corp. filed a Form 8-K on September 15, 2026, disclosing that its wholly owned subsidiary, Starz Entertainment, LLC, entered into a new employment agreement with Alison Hoffman, President, Starz Networks, on September 11, 2026.
Avidia Bancorp, Inc. filed an 8-K with the Securities and Exchange Commission on September 15, 2026, reporting the final vote results from its Annual Meeting of Stockholders held on the same date.
Pulse Biosciences, Inc. filed a Form 8-K on September 15, 2026, disclosing entry into a new equity distribution agreement with Mizuho Securities USA LLC for at-the-market sales of common stock with an aggregate offering price of up to $85,000,000, and the simultaneous termination of …
XMAX Inc. filed a Form 8-K on September 15, 2026, disclosing that it received a Nasdaq notification letter on September 10, 2026, citing non-compliance with Nasdaq Listing Rule 5635(d) for issuing shares without prior shareholder approval.
CDW Corporation filed a Form 8-K on September 15, 2026, disclosing that its subsidiaries CDW LLC and CDW Finance Corporation entered into an underwriting agreement on September 14, 2026 to issue $1.5 billion in aggregate principal of senior notes across three tranches in a …
Safety Insurance Group, Inc. filed a Form 8-K on September 15, 2026, reporting that the required Hart-Scott-Rodino Antitrust Improvements Act waiting period for its proposed merger with MAPFRE U.S.A. Corp. expired at 11:59 p.m. Eastern Time on September 14, 2026.
Deckers Outdoor Corporation filed an 8-K current report on September 15, 2026, disclosing the final voting results from its 2026 Annual Meeting of Stockholders held virtually on September 14, 2026.
Beta Bionics, Inc. filed an 8-K with the U.S. Securities and Exchange Commission on September 15, 2026, disclosing FDA clearance of its Mint patch pump and submission of a 510(k) application for its 3D Intelligence insulin dosing algorithm, both announced on September 14, 2026.
Mark Hopman, Chief Commercial Officer of Beta Bionics, Inc. (NASDAQ:BBNX), filed a Form 4 on September 15, 2026, disclosing the sale of 775 shares of common stock on September 14, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
JBS N.V. filed a Form 8-K on September 15, 2026, disclosing that its wholly-owned Brazilian subsidiary JBS S.A. entered into an association agreement with Viva Holding Ltda. to combine both companies' leather production, processing, and commercialization assets into a new joint entity to be …